107 related articles for article (PubMed ID: 11413676)
1. [Renal excretion of methotrexate in an in vivo model in minipigs].
Cermanová J; Chládek J; Sispera L; Martínková J
Acta Medica (Hradec Kralove) Suppl; 2000; 43(2):139-47. PubMed ID: 11413676
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of renal tubular transport of methotrexate by probenecid.
Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
[TBL] [Abstract][Full Text] [Related]
3. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
Chládková J; Hak J; Martínková J; Chládek J
Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
[TBL] [Abstract][Full Text] [Related]
4. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
Kremer JM; Petrillo GF; Hamilton RA
J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
[TBL] [Abstract][Full Text] [Related]
6. [Severe renal impairment of methotrexate elimination after high dose therapy].
Lawrenz-Wolf B; Wolfrom C; Frickel C; Fengler R; Wehinger H; Henze G
Klin Padiatr; 1994; 206(4):319-26. PubMed ID: 7967432
[TBL] [Abstract][Full Text] [Related]
7. Urinary pH and urine flow independent renal clearance of methotrexate in dogs.
Lui CY; Lee MG; Chiou WL
J Pharmacokinet Biopharm; 1985 Apr; 13(2):159-71. PubMed ID: 4057055
[TBL] [Abstract][Full Text] [Related]
8. Effects of morphine on methotrexate disposition in mice.
Li Y; Looney GA; Hurwitz A
Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):267-70. PubMed ID: 15053825
[TBL] [Abstract][Full Text] [Related]
9. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
10. Effect of urine pH and flow on renal clearance of methotrexate.
Sand TE; Jacobsen S
Eur J Clin Pharmacol; 1981; 19(6):453-6. PubMed ID: 7250179
[TBL] [Abstract][Full Text] [Related]
11. Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.
Statkevich P; Fournier DJ; Sweeney KR
J Pharmacol Exp Ther; 1993 Jun; 265(3):1118-24. PubMed ID: 8509997
[TBL] [Abstract][Full Text] [Related]
12. Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy.
Christophidis N; Louis WJ; Lucas I; Moon W; Vajda FJ
Cancer Chemother Pharmacol; 1981; 6(1):59-64. PubMed ID: 7273267
[TBL] [Abstract][Full Text] [Related]
13. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
Hempel L; Misselwitz J; Fleck C; Kentouche K; Leder C; Appenroth D; Rost M; Zintl F
Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
[TBL] [Abstract][Full Text] [Related]
14. Some observations on the human pharmacology of methotrexate.
Calvert AH; Bondy PK; Harrap KR
Cancer Treat Rep; 1977 Dec; 61(9):1647-56. PubMed ID: 597817
[TBL] [Abstract][Full Text] [Related]
15. Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model.
Tamhane M; Chakilam AR; Jayaraj A; Thakkar V; Taft DR
Drug Dev Ind Pharm; 2010 Mar; 36(3):315-22. PubMed ID: 20170280
[TBL] [Abstract][Full Text] [Related]
16. A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity.
Woillard JB; Debord J; Benz-de-Bretagne I; Saint-Marcoux F; Turlure P; Girault S; Abraham J; Choquet S; Marquet P; Barin-Le Guellec C
Ther Drug Monit; 2017 Apr; 39(2):145-156. PubMed ID: 28196047
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats.
Park JM; Moon CH; Lee MG
Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):353-62. PubMed ID: 8896046
[TBL] [Abstract][Full Text] [Related]
18. The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.
Iven H; Brasch H
Cancer Chemother Pharmacol; 1988; 21(4):337-42. PubMed ID: 3370743
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of low dose methotrexate in rheumatoid arthritis.
Seideman P; Müller-Suur R; Ekman E
J Rheumatol; 1993 Jul; 20(7):1126-8. PubMed ID: 8371203
[TBL] [Abstract][Full Text] [Related]
20. Theoretically required urinary flow during high-dose methotrexate infusion.
Sasaki K; Tanaka J; Fujimoto T
Cancer Chemother Pharmacol; 1984; 13(1):9-13. PubMed ID: 6733846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
